What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
Oncology Today with Dr Neil Love · Dr. Neil Love
October 6, 202347m 30s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Professor Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here